NM_052998.4:c.862G>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_052998.4(AZIN2):​c.862G>T​(p.Ala288Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00692 in 1,614,204 control chromosomes in the GnomAD database, including 567 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.011 ( 73 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 494 hom. )

Consequence

AZIN2
NM_052998.4 missense

Scores

2
8
6

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 10.0

Publications

8 publications found
Variant links:
Genes affected
AZIN2 (HGNC:29957): (antizyme inhibitor 2) The protein encoded by this gene belongs to the antizyme inhibitor family, which plays a role in cell growth and proliferation by maintaining polyamine homeostasis within the cell. Antizyme inhibitors are homologs of ornithine decarboxylase (ODC, the key enzyme in polyamine biosynthesis) that have lost the ability to decarboxylase ornithine; however, retain the ability to bind to antizymes. Antizymes negatively regulate intracellular polyamine levels by binding to ODC and targeting it for degradation, as well as by inhibiting polyamine uptake. Antizyme inhibitors function as positive regulators of polyamine levels by sequestering antizymes and neutralizing their effect. This gene encodes antizyme inhibitor 2, the second member of this gene family. Like antizyme inhibitor 1, antizyme inhibitor 2 interacts with all 3 antizymes and stimulates ODC activity and polyamine uptake. However, unlike antizyme inhibitor 1, which is ubiquitously expressed and localized in the nucleus and cytoplasm, antizyme inhibitor 2 is predominantly expressed in the brain and testis and localized in the endoplasmic reticulum-golgi intermediate compartment. Recent studies indicate that antizyme inhibitor 2 is also expressed in specific cell types in ovaries, adrenal glands and pancreas, and in mast cells. The exact function of this gene is not known, however, available data suggest its role in cell growth, spermiogenesis, vesicular trafficking and secretion. Accumulation of antizyme inhibitor 2 has also been observed in brains of patients with Alzheimer's disease. There has been confusion in literature and databases over the nomenclature of this gene, stemming from an earlier report that a human cDNA clone (identical to ODCp/AZIN2) had arginine decarboxylase (ADC) activity (PMID:14738999). Subsequent studies in human and mouse showed that antizyme inhibitor 2 was devoid of arginine decarboxylase activity (PMID:19956990). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024927258).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0924 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_052998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AZIN2
NM_052998.4
MANE Select
c.862G>Tp.Ala288Ser
missense
Exon 9 of 12NP_443724.1
AZIN2
NM_001301825.1
c.862G>Tp.Ala288Ser
missense
Exon 6 of 9NP_001288754.1
AZIN2
NM_001293562.2
c.862G>Tp.Ala288Ser
missense
Exon 8 of 11NP_001280491.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AZIN2
ENST00000294517.11
TSL:1 MANE Select
c.862G>Tp.Ala288Ser
missense
Exon 9 of 12ENSP00000294517.6
AZIN2
ENST00000373441.1
TSL:1
c.862G>Tp.Ala288Ser
missense
Exon 6 of 9ENSP00000362540.1
AZIN2
ENST00000373443.7
TSL:1
c.862G>Tp.Ala288Ser
missense
Exon 8 of 11ENSP00000362542.3

Frequencies

GnomAD3 genomes
AF:
0.0111
AC:
1688
AN:
152194
Hom.:
74
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0639
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.0998
Gnomad SAS
AF:
0.00745
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.0249
AC:
6251
AN:
251436
AF XY:
0.0199
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.118
Gnomad ASJ exome
AF:
0.00188
Gnomad EAS exome
AF:
0.0992
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.000791
Gnomad OTH exome
AF:
0.0184
GnomAD4 exome
AF:
0.00649
AC:
9494
AN:
1461892
Hom.:
494
Cov.:
31
AF XY:
0.00587
AC XY:
4272
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33480
American (AMR)
AF:
0.111
AC:
4945
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00226
AC:
59
AN:
26136
East Asian (EAS)
AF:
0.0791
AC:
3139
AN:
39700
South Asian (SAS)
AF:
0.00380
AC:
328
AN:
86258
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53420
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.000351
AC:
390
AN:
1112010
Other (OTH)
AF:
0.00979
AC:
591
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
593
1187
1780
2374
2967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0110
AC:
1682
AN:
152312
Hom.:
73
Cov.:
32
AF XY:
0.0122
AC XY:
909
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00152
AC:
63
AN:
41564
American (AMR)
AF:
0.0635
AC:
972
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.0995
AC:
515
AN:
5178
South Asian (SAS)
AF:
0.00746
AC:
36
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000720
AC:
49
AN:
68034
Other (OTH)
AF:
0.0170
AC:
36
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
79
158
237
316
395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00601
Hom.:
141
Bravo
AF:
0.0174
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.0204
AC:
2475
Asia WGS
AF:
0.0400
AC:
139
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.000711

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.53
D
Eigen
Uncertain
0.68
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.84
T
PhyloP100
10
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.39
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0020
D
Polyphen
0.28
B
Vest4
0.44
MPC
0.40
ClinPred
0.060
T
GERP RS
5.7
Varity_R
0.61
gMVP
0.40
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16835244; hg19: chr1-33562416; API